SIRT3 expression levels were significantly downregulated in the metastatic tissues and highly metastatic cell lines of ovarian cancer, and overexpressed SIRT3 inhibited EMT and ovarian cancer metastasis [76]. Here, SIRT3 is linked to ovarian carcinoma.